Storico di ricavi, utili e flussi di cassa dai bilanci ufficiali.
AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures.
Vedi grafici interattivi e bilanci completi → Modello di valutazione (DCF) →
| Conto economico | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Entrate totali | $3.9B | $3.8B | $3.6B | $3.5B | $3.3B | $3.2B | $2.9B | $2.9B | $2.8B | $2.5B | $2.3B | $2.3B | $2.6B | $2.5B | $2.3B | $2.3B | $2.1B | $1.8B | $2.1B | $1.9B | $1.6B |
| Utile lordo | $1.1B | $1.1B | $1.4B | $1.3B | $1.2B | $1.2B | $1.1B | $1.0B | $952M | $865M | $833M | $814M | $843M | $811M | $741M | $769M | $698M | $616M | $660M | $608M | $515M |
| Margine lordo% | 28.3% | 29.6% | 37.8% | 36.2% | 35.0% | 35.8% | 37.1% | 36.4% | 34.4% | 35.0% | 35.7% | 35.1% | 32.4% | 32.2% | 31.8% | 32.9% | 33.6% | 33.5% | 31.9% | 32.1% | 32.2% |
| Risultato Operativo (EBIT) | $487M | $512M | $496M | $404M | $379M | $347M | $339M | $372M | $286M | $322M | $310M | $324M | $306M | $285M | $259M | $287M | $268M | $206M | $228M | $211M | $162M |
| Margine operativo % | 12.4% | 13.6% | 13.9% | 11.6% | 11.4% | 10.8% | 11.6% | 13.0% | 10.3% | 13.0% | 13.3% | 14.0% | 11.8% | 11.3% | 11.1% | 12.3% | 12.9% | 11.2% | 11.0% | 11.1% | 10.1% |
| Reddito netto | $363M | $393M | $375M | $284M | $239M | $244M | $214M | $242M | $195M | $220M | $206M | $199M | $192M | $172M | $163M | $184M | $173M | $125M | $153M | $142M | $103M |
| Margine netto% | 9.2% | 10.4% | 10.4% | 8.2% | 7.2% | 7.6% | 7.3% | 8.5% | 7.0% | 8.9% | 8.8% | 8.6% | 7.4% | 6.8% | 7.0% | 7.9% | 8.3% | 6.8% | 7.4% | 7.5% | 6.4% |
| EBITDA | $822M | $831M | $777M | $664M | $609M | $587M | $556M | $572M | $476M | $490M | $470M | $468M | $460M | $447M | $397M | $426M | $402M | $334M | $371M | $343M | $276M |
| Utile per azione (EPS) | $5.53 | $5.89 | $5.53 | $4.25 | $3.59 | $3.61 | $3.21 | $3.66 | $3.00 | $3.41 | $3.17 | $3.09 | $2.85 | $2.52 | $2.38 | $2.65 | $2.48 | $1.79 | $2.18 | $1.98 | $1.43 |
| Azioni in circolazione (M) | 65M | 67M | 68M | 67M | 67M | 68M | 67M | 66M | 65M | 65M | 65M | 64M | 67M | 68M | 68M | 69M | 70M | 70M | 71M | 72M | 72M |
Fonte: bilanci pubblici della società (SEC). Verificare su SEC EDGAR prima di fare affidamento su qualsiasi cifra.
Stati patrimoniali, flussi di cassa, dati trimestrali e indici completi nel visualizzatore interattivo di ATR. /companies/us/ATR
Le informazioni di questo sito sono solo a scopo educativo e informativo; non costituiscono consulenza finanziaria. Non vengono pubblicati prezzi obiettivo né raccomandazioni.
About TickerBase · Data methodology & sources · Privacy · Terms